Pear Therapeutics featured in latest issue of Neurotech Insights

Pear Therapeutics CEO, Corey McCann MD, PhD, was interviewed during the 3rd European Neurotech Investing and Partnering Summit held on September 9-10 in Geneva, Switzerland.

Read Full Article Here